Kimberly A. McBennett, MD, PhD

Associate Professor
Case Western Reserve University

Poster(s):

• (116) Associations between lung T1-MRI, chest CT, and multiple breath washout in young children with mild CF lung disease
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (185) Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating or residual function mutation
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (229) Impact of cystic fibrosis transmembrane conductance regulator(CFTR) modulator therapy on nutritional status, hepatic steatosis, and dyslipidemia
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (248) Self-reported adherence with concomitant medications by adults with cystic fibrosis after starting elexacaftor/tezacaftor/ivacaftor therapy
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (507) PHASE 1/2a RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY: SAFETY, PK, AND EFFICACY OUTCOME MEASURES OF INHALED GALLIUM CITRATE (AR-501) IN CYSTIC FIBROSIS PATIENTS
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET